STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
249.28
+0.93 (0.37%)
Feb 17, 2026, 11:56 AM EST - Market open
STERIS Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 5,828 | 5,460 | 5,139 | 4,536 | 4,223 | 3,108 | |
Revenue Growth (YoY) | 7.96% | 6.24% | 13.28% | 7.41% | 35.91% | 2.53% |
Cost of Revenue | 3,245 | 3,041 | 2,902 | 2,556 | 2,340 | 1,764 |
Gross Profit | 2,583 | 2,419 | 2,236 | 1,981 | 1,883 | 1,343 |
Selling, General & Admin | 1,383 | 1,323 | 1,227 | 1,070 | 1,117 | 695.69 |
Research & Development | 111.75 | 107.65 | 103.68 | 98.48 | 86.66 | 66.33 |
Operating Expenses | 1,494 | 1,431 | 1,330 | 1,169 | 1,203 | 762.01 |
Operating Income | 1,089 | 988.23 | 906.01 | 811.97 | 679.77 | 581.09 |
Interest Expense | -62.76 | -86.26 | -144.35 | -107.96 | -89.49 | -37.18 |
Interest & Investment Income | 7.5 | 7.5 | 9.98 | - | 6.28 | 6.35 |
Other Non Operating Income (Expenses) | -14.2 | - | - | -2.88 | - | - |
EBT Excluding Unusual Items | 1,019 | 909.47 | 771.64 | 701.14 | 596.56 | 550.25 |
Merger & Restructuring Charges | -39.34 | -73.44 | -69.89 | -23.97 | -201.95 | -32.72 |
Gain (Loss) on Sale of Investments | 1.01 | 0.91 | 1.06 | - | - | - |
Gain (Loss) on Sale of Assets | 7.43 | 7.43 | - | - | - | - |
Legal Settlements | -48.15 | -48.15 | - | - | - | - |
Other Unusual Items | - | - | - | 3.1 | -27.81 | - |
Pretax Income | 940.11 | 796.21 | 702.81 | 680.27 | 366.8 | 517.53 |
Income Tax Expense | 228.45 | 184.65 | 149.53 | 124.07 | 82.34 | 120.66 |
Earnings From Continuing Operations | 711.66 | 611.56 | 553.28 | 556.2 | 284.46 | 396.87 |
Earnings From Discontinued Operations | -0.78 | 4.52 | -173.2 | -450.38 | -41.59 | - |
Net Income to Company | 710.87 | 616.07 | 380.08 | 105.81 | 242.87 | 396.87 |
Minority Interest in Earnings | -3.13 | -1.43 | -1.84 | 1.22 | 1.02 | 0.53 |
Net Income | 707.74 | 614.64 | 378.24 | 107.03 | 243.89 | 397.4 |
Net Income to Common | 707.74 | 614.64 | 378.24 | 107.03 | 243.89 | 397.4 |
Net Income Growth | 51.35% | 62.50% | 253.39% | -56.12% | -38.63% | -2.52% |
Shares Outstanding (Basic) | 98 | 99 | 99 | 100 | 98 | 85 |
Shares Outstanding (Diluted) | 99 | 99 | 99 | 100 | 98 | 86 |
Shares Change (YoY) | -0.49% | -0.29% | -0.89% | 1.95% | 14.47% | 0.30% |
EPS (Basic) | 7.20 | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 |
EPS (Diluted) | 7.16 | 6.21 | 3.81 | 1.07 | 2.48 | 4.63 |
EPS Growth | 51.78% | 63.01% | 256.71% | -56.92% | -46.50% | -2.73% |
Free Cash Flow | 917.1 | 778 | 612.95 | 394.98 | 397.25 | 450.38 |
Free Cash Flow Per Share | 9.29 | 7.85 | 6.17 | 3.94 | 4.04 | 5.24 |
Dividend Per Share | 2.400 | 2.230 | 2.030 | 1.840 | 1.690 | 1.570 |
Dividend Growth | 10.09% | 9.85% | 10.33% | 8.88% | 7.64% | 8.28% |
Gross Margin | 44.32% | 44.31% | 43.52% | 43.66% | 44.59% | 43.22% |
Operating Margin | 18.68% | 18.10% | 17.63% | 17.90% | 16.10% | 18.70% |
Profit Margin | 12.14% | 11.26% | 7.36% | 2.36% | 5.78% | 12.79% |
Free Cash Flow Margin | 15.74% | 14.25% | 11.93% | 8.71% | 9.41% | 14.49% |
EBITDA | 1,575 | 1,464 | 1,356 | 1,235 | 1,112 | 800.33 |
EBITDA Margin | 27.02% | 26.82% | 26.39% | 27.21% | 26.33% | 25.75% |
D&A For EBITDA | 486.22 | 476.22 | 450.07 | 422.53 | 432.15 | 219.24 |
EBIT | 1,089 | 988.23 | 906.01 | 811.97 | 679.77 | 581.09 |
EBIT Margin | 18.68% | 18.10% | 17.63% | 17.90% | 16.10% | 18.70% |
Effective Tax Rate | 24.30% | 23.19% | 21.28% | 18.24% | 22.45% | 23.32% |
Revenue as Reported | 5,828 | 5,460 | 5,139 | 4,536 | 4,223 | 3,108 |
Advertising Expenses | - | 19.95 | 25.47 | 21.67 | 15.6 | 6.8 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.